Intraocular Anti-VEGF Compared With Intraocular Triamcinolone in Patients With Diabetic Macular Edema
Condition(s):Diabetic Macular EdemaLast Updated:April 4, 2016Completed
Hide Studies Not Open or Pending
Condition(s):Diabetic Macular EdemaLast Updated:April 4, 2016Completed
Condition(s):Diabetic Macular EdemaLast Updated:January 2, 2018Completed
Condition(s):Diabetic Macular EdemaLast Updated:April 2, 2009Completed
Condition(s):Diabetic Macular Edema; Macular Edema, Cystoid; Vision Disorders; Clinically Significant Macular EdemaLast Updated:October 3, 2012Completed
Condition(s):Diabetic Macular EdemaLast Updated:March 14, 2019Completed
Condition(s):Diabetic Macular EdemaLast Updated:August 21, 2018Unknown status
Condition(s):Diabetic Macular EdemaLast Updated:August 22, 2017Withdrawn
Condition(s):Diabetic Macular EdemaLast Updated:February 13, 2023Completed
Condition(s):Diabetic Macular EdemaLast Updated:December 4, 2014Completed
Condition(s):Diabetic Macular EdemaLast Updated:March 8, 2018Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.